Several new treatment options have become available for pancreatic ductal adenocarcinoma (PDAC), but the support for their use for resectable, borderline resectable and locally advanced PDAC is unclear. | Opinions and use of neoadjuvant therapy for resectable borderline resectable and locally advanced pancreatic cancer International survey and case-vignette study